|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 277, Issue 11, 8912-8919, March 15, 2002
From the Unit of Pharmacology, Department of Neuroscience, School
of Medicine, University of Naples Federico II, Naples 80131, Italy
The K+ channels encoded by the
human Ether-a-gogo Related Gene-1 (hERG1) are
crucially involved in controlling heart and brain excitability and are
selectively influenced by reactive oxygen species (ROS). To localize
the molecular regions involved in ROS-induced modulation of hERG1,
segmental exchanges between the ROS-sensitive hERG1 and the
ROS-insensitive bovine ether-a-gogo gene (bEAG) K+ channels
were generated, and the sensitivity of these chimeric channels to ROS
was studied with the two-microelectrode voltage-clamp technique upon
their expression in Xenopus oocytes. Substitution of the
S5-S6 linker of hERG1 with the corresponding
bEAG region removed channel sensitivity to ROS, whereas the reverse
chimeric exchange introduced ROS sensitivity into bEAG. Mutation of
each of the two hERG1 histidines at positions 578 and 587 within the S5-S6 linker generated K+ channels
insensitive to modulation by ROS. In addition, the two iron chelators
desferrioxamine (1 mM) and o-phenanthroline
(0.2 mM) significantly inhibited hERG1 outward
K+ currents and prevented hERG1 inhibition induced by the
ROS-scavenging enzyme catalase (1000 units/ml). Finally, the
hERG1-inhibitory effect exerted by the iron chelators was prevented by
the hERG1 H578D/H587Y double mutation. Collectively, the results
obtained suggest that histidines at positions 578 and 587 in the
S5-S6 linker region of hERG1 K+
channels are crucial players in ROS-induced modulation of hERG1 K+ channels.
A Visiting Scientist at the Section of Pharmacology, Dept. of
Neurosciences, School of Medicine, University Naples Federico II,
Naples, Italy, on leave from the Rammelkamp Center for Education and
Research, Case Western Reserve University, School of
Medicine, Cleveland, OH 44109-1998.
§
To whom correspondence should be addressed: Section of
Pharmacology, Dept. of Neuroscience, School of Medicine, Via. S. Pansini 5, Naples 80131, Italy. Tel.: 39-081-746-3318; Fax:
39-081-746-3323; E-mail: mtaglial@unina.it.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||